Prosecution Insights
Prosecution Insights
7 pending office actions • 3 art units • 6 examiners • 0 of 7 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (29%) |
| Double-patenting + other | 4 (57%) |
| Multi-statute (no §101) | 1 (14%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOLLAND, PAUL J | 2 | 57.3% | +64.7% |
| BENAVIDES, JENNIFER ANN | 1 | 51.3% | +48.6% |
| NOAKES, SUZANNE MARIE | 1 | 73.3% | +18.1% |
| STEADMAN, DAVID J | 1 | 57.7% | +29.5% |
| MCKNIGHT, CIARA A | 1 | 59.2% | +38.1% |
| SWIFT, CANDICE LEE | 1 | 57.4% | +36.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19358181 | METHODS OF TREATING TUMORS | BENAVIDES, JENNIFER ANN | 2d overdue |
| 19071092 | PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF | NOAKES, SUZANNE MARIE | — |
| 18922889 | PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF | MCKNIGHT, CIARA A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19071055 | PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF | HOLLAND, PAUL J | 141d overdue |
| 19071264 | PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF | STEADMAN, DAVID J | 125d overdue |
| 19358181 | METHODS OF TREATING TUMORS | BENAVIDES, JENNIFER ANN | 2d overdue |
| 19071092 | PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF | NOAKES, SUZANNE MARIE | — |
| 19071005 | PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF | HOLLAND, PAUL J | — |
| 18922889 | PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF | MCKNIGHT, CIARA A | — |
| 17376517 | SUBCUTANEOUS TELOMERASE INHIBITOR COMPOSITIONS AND METHODS FOR USING SAME | SWIFT, CANDICE LEE | — |
| Art Unit | Apps |
|---|---|
| 1656 | 5 |
| 1675 | 1 |
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19358181 | METHODS OF TREATING TUMORS | BENAVIDES, JENNIFER ANN | 1675 | §103§112Other | Non-Final OA | 2d overdue | Pending | Oct 14, 2025 |
| 19071092 | PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF | NOAKES, SUZANNE MARIE | 1656 | §101§112DP | Non-Final OA | — | Pending | Mar 05, 2025 |
| 19071264 | PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF | STEADMAN, DAVID J | 1656 | §112DP | Non-Final OA | 125d overdue | Pending | Mar 05, 2025 |
| 19071005 | PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF | HOLLAND, PAUL J | 1656 | §112DP | Non-Final OA | — | Pending | Mar 05, 2025 |
| 19071055 | PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF | HOLLAND, PAUL J | 1656 | §112DP | Non-Final OA | 141d overdue | Pending | Mar 05, 2025 |
| 18922889 | PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF | MCKNIGHT, CIARA A | 1656 | §101§112DP | Non-Final OA | — | Pending | Oct 22, 2024 |
| 17376517 | SUBCUTANEOUS TELOMERASE INHIBITOR COMPOSITIONS AND METHODS FOR USING SAME | SWIFT, CANDICE LEE | 1657 | §103DP | Final Rejection | — | Pending | Jul 15, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial